Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy

Diabetes

Volumn 46, Issue 7, 1997, Pages 1182-1188

  Nielsen, Flemming S ^a   Rossing, Peter ^a   Gall, Mari Anne ^a   Skøtt, Peter ^a   Smidt, Ulla M ^a   Parving, Hans Henrik ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EDETATE CHROMIUM CR 51; FUROSEMIDE; HEMOGLOBIN A1C; HYDRALAZINE; INSULIN; LISINOPRIL; ORAL ANTIDIABETIC AGENT; PENTETATE TECHNETIUM TC 99M; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIET THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INSULIN TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; LONG TERM CARE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE;

EID: 0030980370     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.7.1182     Document Type: Article

References (43)

1. Tarnow L, Rossing P, Gall M-A, Nielsen FS, Parving H-H: Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care 17:1247-1251, 1994
2. Parving H-H: Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitiis. Diabetes Care 14:260-269, 1991
3. Rossing P, Hommel E, Smidt UM, Parving H-H: Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 42:715-719, 1993
4. Hosterter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19:410-415, 1981
5. Jensen PK, Steven K, Blæhr H, Christiansen JS, Parving H-H: Effects of indomethacin on glomerular hemodynaniics in experimental diabetes. Kidney Int 29:490-495, 1986
6. Berkman J, Rifkin H: Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson). Metabolism 22:715-722, 1973
7. Berionade VC, Legevre R, Falardeau P: Unilateral nodular diabetic glomerulosclerosis: recurrence of an experiment of nature. Am J Nephrol 7:55-59, 1987
8. Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomendopathies. Am J Med 72:375-380, 1982
9. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
10. Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285:685-688, 1982
11. Parving H-H, Andersen AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet i:175-1179, 1983
12. Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M: Beneficial effect of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 293:471-474, 1986
13. Parving H-H, Hommel E, Smidt UM: Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. Br Med J 297:1086-1091, 1988
14. Parving H-H, Hommel E: Prognosis in diabetic nephropathy. Br Med J 299:230-233, 1989
15. Lewis E, Hunsicker L, Bain R, Rhode R: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
16. Björck S, Mulec H, Johnsen SA, Nordén G, Aurell M: Renal protective effect of enalapril in diabetic nephropathy. Br Med J 304:339-343, 1992
17. Chan JCN, Cockram CS, Nicholls MG, Cheung CK, Swaminathan R: Comparison of enalapril and nifedipine in treating non-insulin dependent diabetics associated with hypertension: one year analysis. Br Med J 305:981-985, 1992
18. Walker WG, Hermann J, Anderson J, Zachary J, Russell RP: Blood pressure (BP) control slows decline of glomerular filtration rate (GFR) in hypertensive NIDDM patients (Abstract). J Am Soc Nephrol 3:339, 1992
19. Lebovitz HE, Wiegmann TB, Cnaan A, Shahinfar S, Sica D, Broadstone V, Schwarte SL, Mengel MC, Segal R, Versaggi JA, Bolten WK; Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria. Kidney Int 45 (Suppl. 45):S150-S155, 1994
20. Bakris GL, Copley JB, Vicknair N, Sadler R, Leurgans S: Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int 50:1641-1650, 1996
21. Nielsen FS, Rossing P, Gall M-A, Skøtt P, Smidt UM, Parving H-H: Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy Diabetes 43:1108-1113, 1994
22. Parving H-H, Gall M-A, Skøtt P, Jørgensen HE, Løkkegaard II, Jørgensen F, Nielsen B, Larsen S: Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 41:758-762, 1992
23. White WB, Pickering TG, Morganroth J, James GD, McCabe EJ, Moucha O, Hunter H: A multicenter evaluation of the A&D TM-2420 ambulatory blood pressure recorder. Am J Hypertens 4:890-896, 1991
24. Jamieson MJ, Fowler G, MacDonald TM, Webster J, Witte K, Lawson L, Crichton W, Jeffers TA, Petrie J: Bench and ambulatory field evaluation of the A&D TM-2420 automated sphygmomanometer. J Hypertens 8:599-605, 1990
25. Clark S, Fowlie S, Coats A, Radaelli A, van der Putt M, Bird R, Conway J: Ambulatory blood pressure monitoring: validation of the accuracy and reliability of the TM-2420 according to the AAMI recommendations. J Hum Hypertens 5:77-82, 1991
26. Bröchner-Mortensen J: A simple method for the determination of glomerular fitration rate. Scand J Clin Lab Invest 30:271-274, 1972
27. Bröchner-Mortensen J, Rödbro P: Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 36:35-43, 1976
28. Feldt-Rasmussen B, Dinesen B, Deckert M: Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45:539-544, 1985
29. Nielsen FS, Voldsgaard AI, Gall M-A, Rossing P, Hommel E, Andersen P, Dyerberg J, Parving H-H: Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy. Diabetotogia 36:438-444, 1993
30. Jacobson HR: Chronic renal failure: pathophysiology. Lancet 338:419-423, 1991
31. Ritz E, Stefanski A: Diabetic nephropathy in type II diabetes. Am J Kidney Dis 27:167-194, 1996
32. Parving H-H, Smidt UM, Friisberg B, Bonnevie-Nielsen V, Andersen AR: A prospective study of glomerular nitration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 20:457-461, 1981
33. Mogensen CE: Progression of nephropathy in long-term diabetics with proteinuria and effect of initial antihypertensive treatment. Scand J Clin Lab Invest 36:383-388, 1976
34. Viberti GC, Bilous RW, Mackintosh D, Keen H: Monitoring glomerular function in diabetic nephropathy. Am J Med 74:256-264, 1983
35. Biesenbach G, Janko O, Zazgornik J: Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus. Nephrol Dial Transplant 9:1097-1102, 1994
36. Parving H-H, Gall M-A, Nielsen FS, Smidt UM: The course of kidney function in albuminuric non-insulin-dependent diabetic (NIDDM) patients with diabetic or non-diabetic glomerulopathy (Abstract). Am J Nephrol 4:307, 1993
37. Bakris GL, Barnhill BW, Sadler R: Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int 41:912-919, 1992
38. Slataper R, Vicknair N, Sadler R, Bakris GL: Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. Arch Intern Med 153:973-980, 1993
39. Parving H-H, Rossing P: The use of antihypertensive agents in prevention and treatment of diabetic nephropathy. Curr Opin Nephrol Hypertens 3:292-300, 1994
40. Hansen HP, Nielsen FS, Rossing P, Jensen B, Parving H-H: Kidney function after withdrawal of long-standing antihypertensive treatment in NIDDM patients with diabetic nephropathy (Abstract). J Am Soc Nephrol 7:1358, 1996
41. Levey AS, Gassman J, Hall PM, Walker WG: Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. J Am Soc Nephrol 1:1087-1094, 1991
42. Lebovitz H, Cnaan A, Wiegmann TB, Broadstone V, Schwartz SL, Sica D, Mengel MC, Versaggi J, Shahinfar S, Bolten WK: Enalapril slows the progression of renal disease in non-insulin dependent diabetes mellitus (NIDDM): results of a 3-yr multicenter, randomized, prospective, double-blinded study (Abstract). J Am Soc Nephrol 3:335, 1992
43. Shemesh O, Golbetz HV, Kriss JP, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 28:830-838, 1985